Cargando…

Expression of Cripto‐1 predicts poor prognosis in stage I non‐small cell lung cancer

Cripto‐1 (CR‐1) is related to the biological behaviour and prognosis of carcinomas. The purpose of this study was to investigate the significance of CR‐1 expression in surgically resected stage I non‐small cell lung cancer (NSCLC). One hundred and forty‐eight patients with completely resected stage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Chunhua, Yuan, Qi, Hu, Huidi, Wang, Wei, Zhang, Qian, Li, Li, Wang, Jiwang, Yang, Rusong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520286/ https://www.ncbi.nlm.nih.gov/pubmed/32697011 http://dx.doi.org/10.1111/jcmm.15518

Ejemplares similares

Elevated serum Cripto‐1 and VEGF levels in patients with non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2022)

Rapid On-Site Evaluation During Radial Endobronchial Ultrasound–Guided Transbronchial Lung Biopsy for the Diagnosis of Peripheral Pulmonary Lesions
por: Xu, Chunhua, et al.
Publicado: (2020)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Prognostic significance of serum osteopontin levels in small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2020)

Clinical significance of cripto-1 expression in lung adenocarcinoma
por: Zhang, Hua, et al.
Publicado: (2017)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

Serum macrophage inhibitory cytokine‐1 as a clinical marker for non–small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2021)

Expression of cripto in Human Pancreatic Tumors
por: Tsutsumi, Masahiro, et al.
Publicado: (1994)

Serum tumour M2‐pyruvate kinase as a biomarker for diagnosis and prognosis of early‐stage non–small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2021)

CRIPTO Is a Marker of Chemotherapy-Induced Stem Cell Expansion in Non-Small Cell Lung Cancer
por: Francescangeli, Federica, et al.
Publicado: (2022)

PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer
por: Li, Ming, et al.
Publicado: (2017)

Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma
por: Wu, Zhengrong, et al.
Publicado: (2009)

PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer: Retraction
por: Li, Ming, et al.
Publicado: (2023)

Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer
por: Kong, Peng-Zhou, et al.
Publicado: (2016)

Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma
por: Liu, Qiang, et al.
Publicado: (2017)

Autoregulation and Heterogeneity in Expression of Human Cripto-1
por: Loying, Pojul, et al.
Publicado: (2015)

CRIPTO-1 Is Immunolocalized in the Syncytiotrophoblast of Ampullary Pregnancies
por: Cabar, Fábio Roberto, et al.
Publicado: (2022)

Cripto-1 Promotes the Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma Cells
por: Huang, Chun, et al.
Publicado: (2015)

Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma
por: Li, Xiao-shan, et al.
Publicado: (2019)

Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome
por: Xue, Yi-Jun, et al.
Publicado: (2019)

Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
por: Hu, Chunxiao, et al.
Publicado: (2021)

Diagnostic Value of Virtual Bronchoscopic Navigation Combined With Endobronchial Ultrasound Guided Transbronchial Lung Biopsy for Peripheral Pulmonary Lesions
por: Xu, Chunhua, et al.
Publicado: (2021)

Expression and functional role of CRIPTO-1 in cutaneous melanoma
por: De Luca, A, et al.
Publicado: (2011)

Cripto haploinsufficiency affects in vivo colon tumor development
por: GIORGIO, EMILIA, et al.
Publicado: (2014)

PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer
por: Fu, Xiao, et al.
Publicado: (2020)

Screening and Validation of Significant Genes with Poor Prognosis in Pathologic Stage-I Lung Adenocarcinoma
por: Deng, Yujie, et al.
Publicado: (2022)

Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis
por: Wang, Kaiyuan, et al.
Publicado: (2019)

CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer
por: Nam, Yunha, et al.
Publicado: (2022)

Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1
por: Watanabe, Kazuhide, et al.
Publicado: (2009)

Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal
por: Freeman, David W., et al.
Publicado: (2021)

Hyaluronic Acid Correlates With Bone Metastasis and Predicts Poor Prognosis in Small-Cell Lung Cancer Patients
por: Zhao, Cong, et al.
Publicado: (2022)

In vivo and in vitro study of co-expression of LMP1 and Cripto-1 in nasopharyngeal carcinoma()
por: Ye, Qing, et al.
Publicado: (2019)

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers
por: Li, Zhenling, et al.
Publicado: (2015)

Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer
por: Liu, Fayong, et al.
Publicado: (2021)

Downregulation of ARID1A is correlated with poor prognosis in non-small cell lung cancer
por: Wang, Tao, et al.
Publicado: (2020)

Oncofetal Protein CRIPTO Is Involved in Wound Healing and Fibrogenesis in the Regenerating Liver and Is Associated with the Initial Stages of Cardiac Fibrosis
por: Karkampouna, Sofia, et al.
Publicado: (2021)

SIX1 Predicts Poor Prognosis and Facilitates the Progression of Non-small Lung Cancer via Activating the Notch Signaling Pathway
por: Huang, Shanshan, et al.
Publicado: (2022)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer()
por: Zhu, Jinhong, et al.
Publicado: (2016)

Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta
por: Bandeira, Carla Letícia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_53tpft77m5mogo6p4qkbapjmaq